Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
| $4.72B | -$211M | 1 | 4.25% | Reduced |
|
| 2 |
Fidelity Investments
Boston,
Massachusetts
| $3.59B | +$505M | 21 | 0.46% | Increased |
|
| 3 |
TS
Third Security
Radford,
Virginia
| $3.03B | -$97.1M | 2 | 79.2% | Reduced |
|
| 4 |
Primecap Management
Pasadena,
California
| $2.3B | +$8.28M | 4 | 2.26% | Increased |
|
| 5 |
QF
QVT Financial
New York
| $1.55B | +$1.59B | 3 | 23.52% | Increased |
|
| 6 |
Vanguard Group
Malvern,
Pennsylvania
| $1.45B | +$204M | 28 | 0.1% | Increased |
|
| 7 |
Capital Research Global Investors
Los Angeles,
California
| $1.41B | +$71.3M | 3 | 0.46% | Increased |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $1.14B | -$5.64M | 12 | 0.23% | Reduced |
|
| 9 |
Wells Fargo
San Francisco,
California
| $1.1B | +$93.4M | 26 | 0.42% | Increased |
|
| 10 |
Brown Brothers Harriman & Co
New York
| $957M | -$36.9M | 2 | 4.48% | Reduced |
|
| 11 |
Blackstone Inc
New York
| $759M | -$442M | 1 | 2.17% | Reduced |
|
| 12 |
Franklin Resources
San Mateo,
California
| $715M | +$98.8M | 16 | 0.32% | Increased |
|
| 13 |
BlackRock Fund Advisors
San Francisco,
California
| $699M | +$32.7M | 23 | 0.17% | Increased |
|
| 14 |
Fisher Asset Management
Camas,
Washington
| $631M | +$14.4M | 2 | 1.23% | Increased |
|
| 15 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $623M | +$380M | 1 | 1.12% | Increased |
|
| 16 |
Northern Trust
Chicago,
Illinois
| $597M | +$45.9M | 25 | 0.18% | Increased |
|
| 17 |
State Street
Boston,
Massachusetts
| $574M | +$54.9M | 19 | 0.06% | Increased |
|
| 18 |
BlackRock Institutional Trust
San Francisco,
California
| $544M | +$54.6M | 26 | 0.09% | Increased |
|
| 19 |
UBS Group
Zurich,
Switzerland
| $535M | +$18.4M | 33 | 0.35% | Increased |
|
| 20 |
Invesco
Atlanta,
Georgia
| $471M | -$30.6M | 17 | 0.19% | Reduced |
|
| 21 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $460M | +$95.2M | 2 | 1.26% | Increased |
|
| 22 |
Managed Account Advisors
Jersey City,
New Jersey
| $407M | -$3.36M | 7 | 0.34% | Reduced |
|
| 23 |
Wellington Management Group
Boston,
Massachusetts
| $404M | -$69M | 9 | 0.1% | Reduced |
|
| 24 |
Morgan Stanley
New York
| $402M | +$56.8M | 35 | 0.14% | Increased |
|
| 25 |
OrbiMed
New York
| $375M | +$165M | 7 | 3.13% | Increased |
|